ACD-A (Haemonetics Manufacturing Inc)


Welcome to the PulseAid listing for the ACD-A drug offered from Haemonetics Manufacturing Inc. This Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Haemonetics Manufacturing Inc
NON-PROPRIETARY NAME: Anticoagulant Citrate Dextrose Solution A
SUBSTANCE NAME: DEXTROSE MONOHYDRATE; SODIUM CITRATE; CITRIC ACID MONOHYDRATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1987-11-06
END MARKETING DATE: 0000-00-00


ACD-A HUMAN PRESCRIPTION DRUG Details:

Item DescriptionACD-A from Haemonetics Manufacturing Inc
LABELER NAME: Haemonetics Manufacturing Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 2.45; 2.2; .73(g/100mL; g/100mL; g/100mL)
START MARKETING DATE: 1987-11-06
END MARKETING DATE: 0000-00-00
PRODUCT ID: 53157-796_ec28b740-2fd1-453e-9ee9-1aa20d223d6c
PRODUCT NDC: 53157-796
APPLICATION NUMBER: NDA710497

Other DEXTROSE MONOHYDRATE; SODIUM CITRATE; CITRIC ACID MONOHYDRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Haemonetics Manufacturing IncACD-A
Terumo BCT LtdACD